LC
LLY icon

Lavaca Capital’s Eli Lilly LLY Stock Holding History

Lavaca Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,800
Closed -$897K – 170
2021
Q1 		$897K Buy
+4,800
New +$939K 0.08% 68

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lavaca Capital's LLY Position: Q2 2026 in Review

Lavaca Capital increased its Eli Lilly (LLY) stake by 26% in Q2 2026, buying an estimated $102K and bringing the position to 486 shares worth $583K. The position accounts for 0.06% of the portfolio, ranked #74.

Lavaca Capital first reported a position in LLY in Q4 2018 and has held it in 26 quarters since. The position peaked at $3.71M in Q4 2021. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lavaca Capital held 486 shares of Eli Lilly worth $583K as of Q2 2026.
  • Lavaca Capital bought 100 Eli Lilly shares in Q2 2026, an estimated $102K.
  • Eli Lilly made up 0.06% of Lavaca Capital's portfolio in Q2 2026, its #74 holding.
  • Lavaca Capital first reported a position in Eli Lilly in Q4 2018 and has held it in 26 quarters since.
  • Lavaca Capital's Eli Lilly position peaked at $3.71M in Q4 2021.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.